Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06235216
Title Sacituzumab govitEcan in THYroid Cancers (SETHY)
Acronym SETHY
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitari Vall d'Hebron RECRUITING Barcelona Spain Details
Complexo Hospitalario Universitario de Ferrol NOT_YET_RECRUITING Ferrol Spain Details
Institut Catala d´Oncologia (ICO) -Hospitalet RECRUITING Hospitalet de Llobregat (Barcelona) Spain Details
Hospital Clínico San Carlos RECRUITING Madrid Spain Details
Hospital Universitario la Paz RECRUITING Madrid Spain Details
Hospital Universitario Ramón y Cajal NOT_YET_RECRUITING Madrid Spain Details
MD Anderson Cancer Center Madrid RECRUITING Madrid Spain Details
Hospital General Universitario Morales Meseguer RECRUITING Murcia Spain Details
Hospital Universitario Central de Asturias RECRUITING Oviedo Spain Details
H.U. Marqués de Valdecilla RECRUITING Santander Spain Details
Hospital Universitario Miguel Servet RECRUITING Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field